Fremanezumab effective in patients with migraine and comorbid depression Presented ByProf. Dawn C. Buse, Albert Einstein College of Medicine, NY, USA TrialPhase 3, FOCUS, HALO ConferenceMTIS 2020 27 October, 2020 15:08
Fremanezumab tolerability in cardiovascular patients with migraine Presented ByDr Gianluca Coppola, Sapienza University of Rome, Italy TrialPhase 3, HALO, FOCUS ConferenceEAN 2020 9 September, 2020 17:05
